Showing results (151-160 of 196) with videos related to
Sort By:
Pageof 20
Iranian Journal of Public Health|May 31, 2018
Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in IranHadi Hayati, Abbas Kebriaeezadeh, Mohammad Ali Ehsani, et al.Mediterranean Journal of Rheumatology|August 27, 2021
A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological MedicinesSaman Zartab, Shekoufeh Nikfar, Naeim Karimpour-Fard, et al.Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|April 3, 2014
A system dynamics model for national drug policyAkbar Abdollahiasl, Abbas Kebriaeezadeh, Rassoul Dinarvand, et al.Medical Journal of the Islamic Republic of Iran|September 5, 2020
A review on inputs and outputs in determining the efficiency of universities of medical sciences by data envelopment analysis methodMohammad M Mojahedian, Aeen Mohammadi, Mohammad Abdollahi, et al.Value in Health Regional Issues|November 18, 2023
Choosing the Best Instrument for Measuring Health Spillover Effect in Caregivers of Patients With Multiple SclerosisHoda Faraji, Fatemeh Soleymani, Mehdi Yaseri, et al.Archives of Medical Science : AMS|July 13, 2013
Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancerAmir Hashemi-Meshkini, Khosro Keshavarz, Zahra Gharibnaseri, et al.Journal of Research in Pharmacy Practice|October 21, 2014
From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?Amir Hashemi-Meshkini, Mehdi Varmaghani, Mehdi Yousefi, et al.Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|November 2, 2023
Towards greater impact in health technology assessment: System dynamic approach for new and emerging technologies in IranZahra Goudarzi, Milad Ahmadi Marzaleh, Shekoufeh Nikfar, et al.Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|May 6, 2019
Providing a framework for assessment of the access to medicineMonireh Afzali, Elahe Khorasani, Mahdi Alvandi, et al.Iranian Journal of Neurology|March 20, 2019
Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysisAmir Hashemi-Meshkini, Hedieh Sadat Zekri, Hasan Karimi-Yazdi, et al.Pageof 20